NCT01731951
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Rochester, Minnesota, United States
Clinical trial condition
Primary Myelofibrosis
Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.
100 public trials
21 recruiting studies
Primary Myelofibrosis trial results
NCT03018223
- Conditions
- Acute Leukemia in Remission, Blood Protein Disorders, Bone Marrow Diseases, +35 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03065400
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
- Locations
-
- Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
NCT00489203
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
- Locations
-
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT03426969
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02966353
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
- Locations
-
- Novartis Investigative Site Vienna, Austria
- Novartis Investigative Site Antwerp, Belgium
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Sofia, Bulgaria
NCT01787552
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Novartis Investigative Site Camperdown, New South Wales, Australia
- Novartis Investigative Site Woolloongabba, Queensland, Australia
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Toronto, Ontario, Canada
NCT00397813
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
- Locations
-
- LDS Hospital Salt Lake City, Utah, United States
- Veterans Administration Center-Seattle Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00856388
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States